SCHEMBL18622735

SCHEMBL18622735

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C(=O)NCCSSCCNC(C)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ CNR1 P21554 3/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PPARA Q07869 1/20 0.37
▸ MTNR1A P48039 2/20 0.36
▸ MTNR1B P49286 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ FAAH O00519 1/20 0.35
▸ FFAR1 O14842 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ RXRA P19793 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ OXER1 Q8TDS5 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18622734 0.87 CNR1 (0.38) ALDH1A1CNR1CNR2SMN1; SMN2PPARA
SCHEMBL18622736 0.81 CNR1 (0.42) TSHRALDH1A1CNR1CNR2SMN1; SMN2
SCHEMBL14739831 0.79 CNR1 (0.64) ALDH1A1CNR1CNR2KMT2AFAAH
SCHEMBL14739832 0.79 CNR1 (0.64) ALDH1A1CNR1CNR2KMT2AFAAH
SCHEMBL14739566 0.77 CNR1 (0.66) ALDH1A1CNR1CNR2KMT2AFAAH
SCHEMBL14739564 0.77 CNR1 (0.66) ALDH1A1CNR1CNR2KMT2AFAAH
SCHEMBL12417784 0.75 CNR1 (0.58) ALDH1A1CNR1CNR2FAAHFFAR1
SCHEMBL917149 0.74 TSHR (0.71) TSHRALDH1A1MTNR1AMTNR1BKMT2A
SCHEMBL2191565 0.72 CNR1 (0.54) ALDH1A1CNR1CNR2FAAHFFAR1
SCHEMBL12507657 0.72 CNR1 (0.54) ALDH1A1CNR1CNR2FAAHFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170073305-A1 FATTY ACID AMIDES, COMPOSITIONS AND METHODS OF USE CATABASIS PHARMACEUTICALS, INC. 2017-03-16 — — US disclosed
US-20170073305-A1 FATTY ACID AMIDES, COMPOSITIONS AND METHODS OF USE CATABASIS PHARMACEUTICALS, INC. 2017-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170073305-A1 FATTY ACID AMIDES, COMPOSITIONS AND METHODS OF USE FASN, FADS1, ELOVL5 TSHR 2989/4885ALDH1A1 810/4885CNR1 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback